Human IFN-γ T cell ELISPOT kit - 2-plate

SKU
CT230-B2
All-inclusive ELISPOT kit with reagents and plates (192 determinations).
Format
2-plate
Price
€ 485
Documentation
Data sheet
Manual
SDS
Reactivity
Human
Category
T cell ELISPOT
Analyte
IFN-γ
Description
Our ELISPOT kits provide a complete, ready-to-use solution for reliable, high-performance ELISPOT assays. Each kit includes all essential components: coating and detection antibodies, streptavidin-HRP, TMB substrate, blocking stock solution, dilution buffer, Tween-20, and high-quality PVDF ELISPOT plates with lids and adhesive plate covers.
Description
IFN-γ is a potent immune regulating cytokine that plays a central role in activating the body’s defense against infections and malignant cells. By enhancing antigen presentation and boosting the activity of T cells and natural killer (NK) cells, IFN-γ drives strong antiviral and anti tumor responses. It is primarily produced by activated T helper 1 (Th1) cells, cytotoxic T cells, γδ T cells, NK cells, and natural killer T (NKT) cells, making it a key indicator of cellular immune activation in research and diagnostic applications.
Alternative names
IFN-γ, IFN-gamma, IFN-g, IFNg, interferon γ, interferon-γ, interferon-gamma, interferon gamma, INF-g, INF-gamma, immune interferon, Type II interferon
Gene ID
3458
Related Products

References

Authors, et al. Title Journal Year Volume Pages
Adriaan de Jongste Three sensitive assays do not provide evidence for circulating HuD-specific T cells in the blood of patients with paraneoplastic neurological syndromes with anti-Hu antibodies Neuro Oncol 2012 14 841-8
Yan Zhou Dominance of the CD4(+) T helper cell response during acute resolving hepatitis A virus infection J Exp Med 2012 209 1481-92
Cirino Botta Immune-modulating effects of the newest cetuximab-based chemoimmunotherapy regimen in advanced colorectal cancer patients J Immunother 2012 35 440-7
Alexander Strom Cellular interferon-γ and interleukin-13 immune reactivity in type 1, type 2 and latent autoimmune diabetes: action LADA 6 Cytokine 2012 58 148-51
Lynda Bererhi Clinical and immunological features of very long-term survivors with a single renal transplant Transpl Int 2012 25 545-54
P Correale Cetuximab ± chemotherapy enhances dendritic cell-mediated phagocytosis of colon cancer cells and ignites a highly efficient colon cancer antigen-specific cytotoxic T-cell response in vitro Int J Cancer 2012 130 1577-89
Xiangmei Wu Prediction of HLA class I-restricted T-cell epitopes of islet autoantigen combined with binding and dissociation assays Autoimmunity 2012 45 176-85
Karsten Buschard Self-glycolipids modulate dendritic cells changing the cytokine profiles of committed autoreactive T cells PLoS One 2012 7 e52639
Wendy Unger Islet-specific CTL cloned from a type 1 diabetes patient cause beta-cell destruction after engraftment into HLA-A2 transgenic NOD/scid/IL2RG null mice PLoS One 2012 7 e49213
Aaron Michels Structure-based selection of small molecules to alter allele-specific MHC class II antigen presentation J Immunol 2011 187 5921-30